Stewart Jeffrey Ryan, EVP and Chief Commercial Officer at AbbVie Inc. ($ABBV), sold shares on the open market twice in the last 365 days for a total of 12.4 million dollars. His most recent sale occurred on March 31, 2025. These transactions rank him 956th among 11,678 individual insiders by sale value, surpassing the average of 8.6 million dollars across 6.37 transactions per insider. He recorded no open market purchases.
| Transaction Date | Company | Ticker | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Feb. 27, 2026 | AbbVie Inc. | $ABBV | Stewart Jeffrey Ryan | EVP, CHIEF COMMERCIAL OFFICER | F | Common Stock, $0.01 par value | 23812 | $232.08 | 84,509.0000 | 1,773,000,000 | 21.98% | 0.00% |
| Feb. 18, 2026 | AbbVie Inc. | $ABBV | Stewart Jeffrey Ryan | EVP, CHIEF COMMERCIAL OFFICER | A | Common Stock, $0.01 par value | 8988 | $0.00 | 108,321.0000 | 1,773,000,000 | 9.05% | 0.00% |
| Feb. 18, 2026 | AbbVie Inc. | $ABBV | Stewart Jeffrey Ryan | EVP, CHIEF COMMERCIAL OFFICER | A | Common Stock, $0.01 par value | 9432 | $0.00 | 99,333.0000 | 1,773,000,000 | 10.49% | 0.00% |
| Feb. 18, 2026 | AbbVie Inc. | $ABBV | Stewart Jeffrey Ryan | EVP, CHIEF COMMERCIAL OFFICER | A | Common Stock, $0.01 par value | 9266 | $0.00 | 89,901.0000 | 1,773,000,000 | 11.49% | 0.00% |
| Feb. 18, 2026 | AbbVie Inc. | $ABBV | Stewart Jeffrey Ryan | EVP, CHIEF COMMERCIAL OFFICER | A | Common Stock, $0.01 par value | 26063 | $0.00 | 80,635.0000 | 1,773,000,000 | 47.76% | 0.00% |
| Feb. 18, 2026 | AbbVie Inc. | $ABBV | Stewart Jeffrey Ryan | EVP, CHIEF COMMERCIAL OFFICER | A | Option (Right to Buy) | 26812 | $0.00 | 26,812.0000 | 1,773,000,000 | 9999.99% | 0.00% |
| March 31, 2025 | AbbVie Inc. | $ABBV | Stewart Jeffrey Ryan | EVP, CHIEF COMMERCIAL OFFICER | M | Common Stock, $0.01 par value | 25700 | $79.02 | 113,404.0000 | 1,773,000,000 | 29.30% | 0.00% |
| March 31, 2025 | AbbVie Inc. | $ABBV | Stewart Jeffrey Ryan | EVP, CHIEF COMMERCIAL OFFICER | S | Common Stock, $0.01 par value | 25700 | $209.49 | 87,704.0000 | 1,773,000,000 | 22.66% | 0.00% |
| March 31, 2025 | AbbVie Inc. | $ABBV | Stewart Jeffrey Ryan | EVP, CHIEF COMMERCIAL OFFICER | S | Common Stock, $0.01 par value | 33132 | $210.54 | 54,572.0000 | 1,773,000,000 | 37.78% | 0.00% |
| March 31, 2025 | AbbVie Inc. | $ABBV | Stewart Jeffrey Ryan | EVP, CHIEF COMMERCIAL OFFICER | M | Option (Right to Buy) | 25700 | $79.02 | 0.0000 | 1,773,000,000 | 100.00% | 0.00% |
| Feb. 28, 2025 | AbbVie Inc. | $ABBV | Stewart Jeffrey Ryan | EVP, CHIEF COMMERCIAL OFFICER | F | Common Stock, $0.01 par value | 20226 | $205.02 | 87,704.0000 | 1,773,000,000 | 18.74% | 0.00% |
| Feb. 13, 2025 | AbbVie Inc. | $ABBV | Stewart Jeffrey Ryan | EVP, CHIEF COMMERCIAL OFFICER | A | Common Stock, $0.01 par value | 19111 | $0.00 | 81,390.0000 | 1,773,000,000 | 30.69% | 0.00% |
| Feb. 13, 2025 | AbbVie Inc. | $ABBV | Stewart Jeffrey Ryan | EVP, CHIEF COMMERCIAL OFFICER | A | Common Stock, $0.01 par value | 7840 | $0.00 | 89,230.0000 | 1,773,000,000 | 9.63% | 0.00% |
| Feb. 13, 2025 | AbbVie Inc. | $ABBV | Stewart Jeffrey Ryan | EVP, CHIEF COMMERCIAL OFFICER | A | Common Stock, $0.01 par value | 9268 | $0.00 | 98,498.0000 | 1,773,000,000 | 10.39% | 0.00% |
| Feb. 13, 2025 | AbbVie Inc. | $ABBV | Stewart Jeffrey Ryan | EVP, CHIEF COMMERCIAL OFFICER | A | Common Stock, $0.01 par value | 9432 | $0.00 | 107,930.0000 | 1,773,000,000 | 9.58% | 0.00% |
| Feb. 13, 2025 | AbbVie Inc. | $ABBV | Stewart Jeffrey Ryan | EVP, CHIEF COMMERCIAL OFFICER | A | Option (Right to Buy) | 33854 | $0.00 | 33,854.0000 | 1,773,000,000 | 9999.99% | 0.00% |
| March 18, 2024 | AbbVie Inc. | $ABBV | Stewart Jeffrey Ryan | EVP, CHIEF COMMERCIAL OFFICER | M | Common Stock, $0.01 par value | 26110 | $61.36 | 121,228.0000 | 1,773,000,000 | 27.45% | 0.00% |
| March 18, 2024 | AbbVie Inc. | $ABBV | Stewart Jeffrey Ryan | EVP, CHIEF COMMERCIAL OFFICER | S | Common Stock, $0.01 par value | 26110 | $178.85 | 95,118.0000 | 1,773,000,000 | 21.54% | 0.00% |
| March 18, 2024 | AbbVie Inc. | $ABBV | Stewart Jeffrey Ryan | EVP, CHIEF COMMERCIAL OFFICER | S | Common Stock, $0.01 par value | 5099 | $179.03 | 90,019.0000 | 1,773,000,000 | 5.36% | 0.00% |
| March 18, 2024 | AbbVie Inc. | $ABBV | Stewart Jeffrey Ryan | EVP, CHIEF COMMERCIAL OFFICER | S | Common Stock, $0.01 par value | 27740 | $178.69 | 62,279.0000 | 1,773,000,000 | 30.82% | 0.00% |
| March 18, 2024 | AbbVie Inc. | $ABBV | Stewart Jeffrey Ryan | EVP, CHIEF COMMERCIAL OFFICER | M | Option (Right to Buy) | 26110 | $61.36 | 0.0000 | 1,773,000,000 | 100.00% | 0.00% |
| Feb. 28, 2024 | AbbVie Inc. | $ABBV | Stewart Jeffrey Ryan | EVP, CHIEF COMMERCIAL OFFICER | F | Common Stock, $0.01 par value | 26121 | $178.99 | 95,118.0000 | 1,773,000,000 | 21.55% | 0.00% |
| Feb. 15, 2024 | AbbVie Inc. | $ABBV | Stewart Jeffrey Ryan | EVP, CHIEF COMMERCIAL OFFICER | A | Common Stock, $0.01 par value | 8810 | $0.00 | 104,131.0000 | 1,773,000,000 | 9.24% | 0.00% |
| Feb. 15, 2024 | AbbVie Inc. | $ABBV | Stewart Jeffrey Ryan | EVP, CHIEF COMMERCIAL OFFICER | A | Common Stock, $0.01 par value | 7840 | $0.00 | 111,971.0000 | 1,773,000,000 | 7.53% | 0.00% |
| Feb. 15, 2024 | AbbVie Inc. | $ABBV | Stewart Jeffrey Ryan | EVP, CHIEF COMMERCIAL OFFICER | A | Common Stock, $0.01 par value | 9268 | $0.00 | 121,239.0000 | 1,773,000,000 | 8.28% | 0.00% |
| Feb. 15, 2024 | AbbVie Inc. | $ABBV | Stewart Jeffrey Ryan | EVP, CHIEF COMMERCIAL OFFICER | A | Option (Right to Buy) | 39085 | $0.00 | 39,085.0000 | 1,773,000,000 | 9999.99% | 0.00% |
| Feb. 15, 2024 | AbbVie Inc. | $ABBV | Stewart Jeffrey Ryan | EVP, CHIEF COMMERCIAL OFFICER | A | Common Stock, $0.01 par value | 33042 | $0.00 | 95,321.0000 | 1,773,000,000 | 53.05% | 0.00% |
| March 13, 2023 | AbbVie Inc. | $ABBV | Stewart Jeffrey Ryan | EVP, CHIEF COMMERCIAL OFFICER | M | Common Stock, $0.01 par value | 21810 | $54.86 | 115,404.0000 | 1,778,000,000 | 23.30% | 0.00% |
| March 13, 2023 | AbbVie Inc. | $ABBV | Stewart Jeffrey Ryan | EVP, CHIEF COMMERCIAL OFFICER | S | Common Stock, $0.01 par value | 21810 | $152.30 | 93,594.0000 | 1,778,000,000 | 18.90% | 0.00% |
| March 13, 2023 | AbbVie Inc. | $ABBV | Stewart Jeffrey Ryan | EVP, CHIEF COMMERCIAL OFFICER | S | Common Stock, $0.01 par value | 31315 | $152.27 | 62,279.0000 | 1,778,000,000 | 33.46% | 0.00% |
| March 13, 2023 | AbbVie Inc. | $ABBV | Stewart Jeffrey Ryan | EVP, CHIEF COMMERCIAL OFFICER | M | Option (Right to Buy) | 21810 | $54.86 | 0.0000 | 1,778,000,000 | 100.00% | 0.00% |
| Feb. 28, 2023 | AbbVie Inc. | $ABBV | Stewart Jeffrey Ryan | EVP, COMMERCIAL OPERATIONS | F | Common Stock, $0.01 par value | 24910 | $154.28 | 93,594.0000 | 1,778,000,000 | 21.02% | 0.00% |
| Feb. 16, 2023 | AbbVie Inc. | $ABBV | Stewart Jeffrey Ryan | EVP, COMMERCIAL OPERATIONS | A | Option (Right to Buy) | 35111 | $0.00 | 35,111.0000 | 1,778,000,000 | 9999.99% | 0.00% |
| Feb. 16, 2023 | AbbVie Inc. | $ABBV | Stewart Jeffrey Ryan | EVP, COMMERCIAL OPERATIONS | A | Common Stock, $0.01 par value | 7842 | $0.00 | 118,504.0000 | 1,778,000,000 | 7.09% | 0.00% |
| Feb. 16, 2023 | AbbVie Inc. | $ABBV | Stewart Jeffrey Ryan | EVP, COMMERCIAL OPERATIONS | A | Common Stock, $0.01 par value | 8812 | $0.00 | 110,662.0000 | 1,778,000,000 | 8.65% | 0.00% |
| Feb. 16, 2023 | AbbVie Inc. | $ABBV | Stewart Jeffrey Ryan | EVP, COMMERCIAL OPERATIONS | A | Common Stock, $0.01 par value | 7486 | $0.00 | 101,850.0000 | 1,778,000,000 | 7.93% | 0.00% |
| Feb. 16, 2023 | AbbVie Inc. | $ABBV | Stewart Jeffrey Ryan | EVP, COMMERCIAL OPERATIONS | A | Common Stock, $0.01 par value | 32085 | $0.00 | 94,364.0000 | 1,778,000,000 | 51.52% | 0.00% |